Patents by Inventor Christopher Earnhart

Christopher Earnhart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polyvalent chimeric OspC vaccinogen and diagnostic antigen
    Patent number: 10466240
    Abstract: Chimeric polyvalent recombinant proteins for use as vaccines and diagnostics for Lyme disease (e.g. in canines and humans) are provided. The chimeric proteins comprise epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types and/or OspE types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: November 5, 2019
    Assignee: Virginia Commonwealth University
    Inventors: Richard T. Marconi, Christopher Earnhart, Lee D. Oliver
  • POLYVALENT CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN
    Publication number: 20180275126
    Abstract: Chimeric polyvalent recombinant proteins for use as vaccines and diagnostics for Lyme disease (e.g. in canines and humans) are provided. The chimeric proteins comprise epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types and/or OspE types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 27, 2018
    Inventors: Richard T. MARCONI, Christopher EARNHART, Lee D. OLIVER
  • Polyvalent chimeric OSPC vaccinogen and diagnostic antigen
    Patent number: 9556239
    Abstract: A chimeric polyvalent recombinant protein for use as a vaccine and diagnostic for Lyme disease is provided. The chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types. The OspC types may be associated with mammaliran Borrelia infections.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: January 31, 2017
    Assignee: Virgina Commonwealth University
    Inventors: Richard T. Marconi, Christopher Earnhart
  • Polyvalent chimeric OspC vaccinogen and diagnostic antigen
    Patent number: 9376472
    Abstract: A chimeric polyvalent recombinant protein for use as a vaccine and diagnostic for Lyme disease is provided. The chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: June 28, 2016
    Assignee: Virginia Commonwealth University
    Inventors: Richard T. Marconi, Christopher Earnhart
  • POLYVALENT CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN
    Publication number: 20160097768
    Abstract: Chimeric polyvalent recombinant proteins for use as vaccines and diagnostics for Lyme disease (e.g. in canines and humans) are provided. The chimeric proteins comprise epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types and/or OspE types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Application
    Filed: October 8, 2015
    Publication date: April 7, 2016
    Inventors: Richard T. MARCONI, Christopher EARNHART, Lee D. OLIVER
  • POLYVALENT CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN
    Publication number: 20150064208
    Abstract: A chimeric polyvalent recombinant protein for use as a vaccine and diagnostic for Lyme disease is provided. The chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types. The OspC types may be associated with mammaliran Borrelia infections.
    Type: Application
    Filed: August 1, 2014
    Publication date: March 5, 2015
    Applicant: VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Richard T. MARCONI, Christopher EARNHART
  • POLYVALENT CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN
    Publication number: 20150044249
    Abstract: A chimeric polyvalent recombinant protein for use as a vaccine and diagnostic for Lyme disease is provided. The chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Application
    Filed: June 9, 2014
    Publication date: February 12, 2015
    Inventors: Richard T. MARCONI, Christopher EARNHART
  • Polyvalent chimeric OspC vaccinogen and diagnostic antigen
    Patent number: 8808705
    Abstract: A chimeric polyvalent recombinant protein for use as a vaccine and diagnostic for Lyme disease is provided. The chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: August 19, 2014
    Assignee: Virginia Commonwealth University
    Inventors: Richard T. Marconi, Christopher Earnhart
  • Polyvalent chimeric OspC vaccinogen and diagnostic antigen
    Patent number: 8778352
    Abstract: A chimeric polyvalent recombinant protein for use as a vaccine and diagnostic for Lyme disease is provided. The chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: July 15, 2014
    Assignee: Virginia Commonwealth University
    Inventors: Richard Thomas Marconi, Christopher Earnhart
  • POLYVALENT CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN
    Publication number: 20130266606
    Abstract: A chimeric polyvalent recombinant protein for use as a vaccine and diagnostic for Lyme disease is provided. The chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Application
    Filed: October 19, 2011
    Publication date: October 10, 2013
    Applicant: VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Richard T. Marconi, Christopher Earnhart
  • Polyvalent chimeric OspC vaccinogen and diagnostic antigen
    Patent number: 7794727
    Abstract: A chimeric polyvalent recombinant protein for use as a vaccine and diagnostic for Lyme disease is provided. The chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: September 14, 2010
    Assignee: Virginia Commonwealth University
    Inventors: Richard Thomas Marconi, Christopher Earnhart
  • Polyvalent Chimeric OspC Vaccinogen and Diagnostic Antigen
    Publication number: 20070178117
    Abstract: A chimeric polyvalent recombinant protein for use as a vaccine and diagnostic for Lyme disease is provided. The chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types. The OspC types may be associated with mammalian Borrelia infections.
    Type: Application
    Filed: November 29, 2006
    Publication date: August 2, 2007
    Inventors: Richard Marconi, Christopher Earnhart